Abstract

Fibrodysplasia Ossificans Progressiva (FOP) is an extremely rare and disabling disorder that affects 1 in 2 million individuals worldwide. It is caused by mutations in bone morphogenetic protein which leads to extra-skeletal ossification of soft tissues in a characteristic cranio-caudal pattern. Hallux valgus, episodic flares and progressive functional disability are characteristic features. The cause of death is often cardio-respiratory failure following thoracic insufficiency.

Highlights

  • Fibrodysplasia ossificans progressiva (FOP) is a rare and disabling disorder with a worldwide prevalence of approximately one in two million individuals [1]

  • Due to the rarity of this condition, the medical fraternity’s awareness of FOP is limited and low diagnosis rates might reflect this lack of knowledge

  • There is no ethnic, racial, gender, or geographic predisposition [2]. It is caused by a heterozygous activation or gain of function mutation in ACTIVIN A receptor or type 1 ACTIVIN LIKE KINASE 2 bone morphogenetic protein [3]. It is characterized by extra-skeletal ossification of soft tissues with episodic flare ups and progressive functional disability [2]

Read more

Summary

Introduction

Fibrodysplasia ossificans progressiva (FOP) is a rare and disabling disorder with a worldwide prevalence of approximately one in two million individuals [1]. There is no ethnic, racial, gender, or geographic predisposition [2] It is caused by a heterozygous activation or gain of function mutation in ACTIVIN A receptor or type 1 ACTIVIN LIKE KINASE 2 bone morphogenetic protein [3]. It is characterized by extra-skeletal ossification of soft tissues with episodic flare ups and progressive functional disability [2]. Fibrodysplasia Ossificans Progressiva (FOP) is an extremely rare and disabling disorder that affects 1 in 2 million individuals worldwide It is caused by mutations in bone morphogenetic protein which leads to extra-skeletal ossification of soft tissues in a characteristic cranio-caudal pattern. The cause of death is often cardio-respiratory failure following thoracic insufficiency

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call